Inflammation is caused by soluble mediators, including prostaglandins, histamine, lysosomal granules, and cytokines or chemokines. Lymphocytes, including natural killer (NK) cells and CD8 + T cells, produce many such factors and thus have a central role in chronic inflammation. Intracellular signaling molecules that regulate the production of inflammatory mediators in lymphocytes remain largely unknown. Therefore, defining unique signaling molecules that are exclusively responsible for the production of inflammatory cytokines promises crucial advancement for existing immunotherapy and antiinflammatory protocols.
A r t i c l e s
Inflammation is caused by soluble mediators, including prostaglandins, histamine, lysosomal granules, and cytokines or chemokines. Lymphocytes, including natural killer (NK) cells and CD8 + T cells, produce many such factors and thus have a central role in chronic inflammation. Intracellular signaling molecules that regulate the production of inflammatory mediators in lymphocytes remain largely unknown. Therefore, defining unique signaling molecules that are exclusively responsible for the production of inflammatory cytokines promises crucial advancement for existing immunotherapy and antiinflammatory protocols.
The activatory receptor NKG2D is ubiquitously expressed on NK cells, and activation via NKG2D results in both a cytotoxic effect on target cells and the production of inflammatory cytokines. After activation, NKG2D recruits tyrosine kinases of the Src family to initiate multiple signaling pathways 1 . Phosphorylation of the adaptor DAP10 at its Tyr-Ile-Asn-Met (YINM) motif by tyrosine kinases leads to the recruitment of phosphatidylinositol-3-OH kinase (PI(3)K) 2 . Tyrosine kinases also phosphorylate the immunoreceptor tyrosine-based activation motif-containing transmembrane adaptor DAP12 (KARAP), which subsequently triggers the signaling proteins Syk and Zap70 (ref. 3) . Lack of DAP12, Syk or Zap70 results in much less NKG2D-mediated production of cytokines 3 . CD137 belongs to the tumor-necrosis factor receptor family and functions as an efficient costimulatory receptor in T cells and B cells 4 . CD137 is not constitutively expressed in NK cells; however, it can be abundantly expressed after interleukin 2 (IL-2)-mediated activation 5 . Mouse CD137 recruits the tyrosine kinase p56 lck (ref. 6 ), yet its functional relevance is not known. When T cells are activated through complexes of the T cell antigen receptor and coreceptor CD3 and are costimulated via CD137, recruitment of the ubiquitin ligases TRAF1 and TRAF2 is essential for activation of the mitogen-activated protein kinases Erk1 and Erk2 (Erk1-Erk2) 7 , Jnk1 and Jnk2 (Jnk1-Jnk2) and p38 (ref. 8) and the transcription factor NF-κB. Despite such observations, the identities of signaling molecules downstream of NKG2D or CD137 that exclusively regulate the production of inflammatory cytokines remain elusive.
Here we found that the kinases Lck, Fyn and PI(3)K (subunits p85α and p110δ) and the signaling protein PLC-γ2 were required for both cytotoxicity and the production of inflammatory cytokines after activation of NK cells through NKG2D or CD137. However, a unique interaction between Fyn and the adaptor ADAP ('adhesionand degranulation-promoting adaptor protein'; also known as Fyn-binding protein, Fyb or SLAP-130) that links upstream signaling to the adaptor Carma1 (CARD11) and the kinase MAP3K7 (Tak1) was exclusively responsible for the production of inflammatory cytokines and chemokines but not for cytotoxicity in mouse and human NK cells. Our results provide a molecular 'blueprint' for targeting unique signaling molecules to decrease the 1 1 2 8 VOLUME 14 NUMBER 11 NOVEMBER 2013 nature immunology A r t i c l e s abundance of inflammatory cytokines in a wide range of autoimmune diseases and cell-mediated immunotherapy.
RESULTS

Inflammatory cytokine production by NK cells
To determine the role of NKG2D and CD137 in the production of inflammatory cytokines, we generated stable EL4 mouse lymphoma cell lines expressing the NK cell-activatory ligands H60 or CD137L. We established two stable EL4 cell lines with low or high surface expression of H60 (ref. 9) (EL4-H60 lo or EL4-H60 hi , respectively) and generated two clones with low or high expression of CD137L (EL4-CD137L lo or EL4-CD137L hi , respectively) (Fig. 1a) . NK cells derived from wild-type mice mediated significantly greater cytotoxicity against both H60-expressing and CD137L-expressing EL4 target cells than against parental EL4 cells; as expected, EL4 target cells with higher ligand expression were lysed to a greater extent (Fig. 1b) . NK cells constitutively express NKG2D; however, expression of CD137 is inducible. Ex vivo analysis of splenic NK cells from C57BL/6 (wild-type) mice revealed only basal CD137 expression ( Supplementary Fig. 1a ). However, culture with IL-2 induced CD137 expression in the majority of NK cells (Supplementary Fig. 1b ). IL-2 (or IL-15) along with IL-12 alone or in combination with IL-18 induced CD137 expression in NK cells ( Supplementary  Fig. 1c ). Infection of wild-type mice with the mouse-adapted human influenza virus strain A/PR/8/34 (PR8; H1N1) increased the in vivo CD137 expression in lung NK cells that was comparable to that of T cells (Supplementary Fig. 1d ).
To confirm the potential of CD137 as an independent activation receptor, we cultured NK cells and T cells with IL-2 and stimulated the mixture with plate-bound monoclonal antibody (mAb) to CD137 or mAb to CD3, alone or in combination, then analyzed the production of interferon-γ (IFN-γ) by intracellular staining. Activation via CD3 stimulated IFN-γ production in CD3 + T cells, but activation via CD137 did not (Fig. 1c) . In contrast, activation via CD137 induced IFN-γ production in CD3 − NK1.1 + NK cells, but activation via CD3 did not (Fig. 1c) . As expected, costimulation of T cells with mAb to CD137 plus mAb to CD3 considerably enhanced the production of IFN-γ (Fig. 1c) . These results revealed that CD137 functioned as an independent activation receptor in NK cells while confirming published findings that it is a costimulatory receptor in T cells 10 . We cultured the H60-or CD137L-expressing EL4 target cells together with wild-type NK cells and analyzed the proinflammatory cytokines and chemokines IFN-γ, GM-CSF, CCL3 (MIP-1α), CCL4 (MIP-1β) and CCL5 (RANTES) in the culture supernatants. Culture of NK cells together with EL4-H60 hi or EL4-CD137L hi targets resulted in a significant increase in these cytokines relative to that of culture of NK cells alone or NK cells cultured with parental EL4 cells (Fig. 1d) . Parental EL4 cells and the stable transfectants expressed similar amounts of the major histocompatibility complex class I molecules H2-K b and H2-D b (data not shown), which suggested that CD137L expression, rather than 'preferential' loss of major histocompatibility complex class I, was responsible for the efficient lysis of CD137L-expressing target cells and the production of cytokines by NK cells. Activation of NK cells via NKG2D and CD137 through the use of plate-bound mAbs resulted in abundant phosphorylation of the kinases Akt, MEK1-MEK2, Erk1-Erk2, p38 and Jnk1-Jnk2 (Supplementary Fig. 2a ). These results demonstrated that activation of NK cells via NKG2D or CD137 resulted in cytotoxicity and the production of proinflammatory cytokines.
NK cell cytotoxicity and cytokine production require Lck Activation of Lck constitutes one of the earliest membrane-proximal signaling events. Therefore, we first assessed the association of Lck with NKG2D and CD137 in NK cells. We cultured NK cells with IL-2, then lysed the nonactivated NK cells, immunoprecipitated proteins with mAb to NKG2D or mAb to CD137 and assessed Lck by immunoblot analysis. This analysis revealed a constitutive association of Lck with CD137 (Fig. 2a) . The absence of Lck from samples immunoprecipitated with mAb to NKG2D revealed a specific association of Lck with CD137 ( Fig. 2a) that can be explained by the presence of A r t i c l e s the Lck-binding motif Cys-Arg-Cys-Pro (CRCP) 6 in the cytoplasmic tail of CD137. Fyn was present in samples immunoprecipitated with mAb to NKG2D or mAb to CD137, albeit in larger amounts with mAb to CD137 (Fig. 2a) . Preincubation of wild-type NK cells with the Lck-specific inhibitor C8863 significantly reduced the secretion of IFN-γ following activation mediated by NKG2D or CD137 but not following activation mediated by IL-12 and IL-18, which uses an activation pathway based on the kinases Jak-Tyk (Fig. 2b) . To further confirm the involvement of Lck in this process, we used Lckspecific small interfering RNA (siRNA) to knock down its expression in NK cells cultured with IL-2. Lck-specific siRNA reduced the expression of Lck, but siRNA with a scrambled sequence did not (Fig. 2c) . Knockdown of Lck significantly reduced the ability of NK cells to mediate cytotoxicity against stable H60-or CD137L-expressing EL4 cell lines (Fig. 2d) . Notably, that reduction in the expression of Lck also significantly reduced the NKG2D-or CD137-mediated production of cytokines and chemokines (Fig. 2e) . Moreover, knockdown of Lck did not alter the ability of NK cells to produce inflammatory cytokines in response to IL-12 and IL-18 ( Fig. 2e) . Collectively, these results provided definitive evidence that Lck was critical for both NK cell-mediated cytotoxicity and NK cell production of cytokines.
Fyn regulates cytotoxicity and the production of cytokines Lck forms a complex with and transphosphorylates Fyn in the lipid raft 11 . To define the role of Fyn in terms of Lck, we stimulated NK cells with plate-bound mAb to NKG2D or mAb to CD137. After that activation, phosphorylation of Fyn increased over time (Fig. 3a) . To further understand the role of Fyn, we used NK cells from Fyn-deficient (Fyn −/− ) mice (Supplementary Fig. 2b ). NK cells obtained from wildtype and Fyn −/− mice and cultured with IL-2 expressed similar amounts of NKG2D and CD137 on the surface (Supplementary Fig. 2c ).
Despite that, the cytotoxicity of Fyn −/− NK cells toward EL4-H60 lo and CD137L-expressing EL4 target cells was significantly less than the cytotoxicity of wild-type NK cells toward those target cells (Fig. 3b) .
However, we did not observe a similarly lower cytotoxicity toward EL4-H60 hi target cells (Fig. 3b) . Activation with plate-bound mAb to NKG2D or mAb to CD137 resulted in significantly augmented production of inflammatory cytokines in Fyn −/− NK cells relative to that in wild-type NK cells (Fig. 3c) . This was not due to generalized hyper-responsiveness of Fyn −/− NK cells, as IL-12-and IL-18-mediated activation resulted in concentrations of secreted cytokines and chemokines similar to those of wild-type NK cells (Fig. 3c) . However, the culture of Fyn −/− NK cells with EL4-H60 hi or EL4-CD137L hi target cells resulted in significantly less secretion of cytokines and chemokines than did the culture of wild-type NK cells with those target cells (Fig. 3d) . We noted that discrepancy between coculture and activation mediated by plate-bound antibody only with Fyn −/− NK cells but not with other mutant NK cells used in this study. Analysis of the translocation of the transcription factors AP-1 and NF-κB in NK cells following NKG2D-or CD137-mediated activation revealed a substantial failure in translocation of the AP-1 subunit c-Jun and of the NF-κB subunit p65 to the nucleus in Fyn −/− NK cells, in contrast to their translocation in wild-type cells (Supplementary Fig. 2d ). Although the basal amount of the transcription factor c-Fos in the nucleus was greater in Fyn −/− NK cells than in wild-type NK cells, its activationinduced translocation to the nucleus seemed to remain unchanged in Fyn −/− NK cells following activation (Supplementary Fig. 2d) . These results demonstrated a dual role for Fyn in linking membraneproximal signals to cytotoxic granule release and cytokine production in NK cells.
The Lck-Fyn complex links to PI(3)K subunits p85a and p110d The Src-homology 3 (SH3) domains of Lck and Fyn interact with the proline-rich region of p85α (the regulatory subunit of PI(3)K) 12 . Two proline-rich regions, KRISPPTPKPRPPRPLPVAP and WNEROPAPALPPKPPKPT, between the amino (N)-terminal SH3 and SH2 domains of p85α have been defined as high-affinity binding (Fig. 4a) . Conversely, the association of p85α with Fyn following NKG2D-or CD137-mediated activation was distinct and strong ( Fig. 4a) . We did reciprocal immunoprecipitation of p85α followed by analysis of its interaction with Lck and Fyn and found a stronger association of Fyn with p85α after activation via CD137 than after activation via NKG2D (Supplementary Fig. 3a ). Despite that difference, activation via either receptor resulted in more phosphorylation of p85α than that in unstimulated NK cells. 
A r t i c l e s
However, CD137-mediated p85α phosphorylation peaked at an earlier time point (5 min) than did that mediated by NKG2D (20 min) (Fig. 4b) .
Successful activation of the p85α regulatory subunit of PI(3)K facilitates recruitment of the catalytic p110δ subunit of PI(3)K 13 . Therefore, to confirm the function of PI(3)K in the cytotoxic effect of NK cells on tumor cells and the production of inflammatory cytokines by NK cells, we used knock-in mice that express a catalytically inactive p110δ subunit due to a point mutation that results in the substitution of alanine for the aspartic acid at position 910 (p110δ(D910A)); this produces p110δ with complete loss of function but normal abundance. The expression of NKG2D and CD137 was similar in wild-type and p110δ(D910A) NK cells ( Supplementary Fig. 3b) ; however, lack of a functional p110δ significantly reduced the ability of NK cells to lyse both H60-expressing EL4 target cells and CD137L-expressing EL4 target cells (Fig. 4c) . Next we analyzed the production of inflammatory cytokines and chemokines. The p110δ(D910A) NK cells produced a significantly lower abundance of cytokines and chemokines after NKG2D-or CD137-mediated activation than did wild-type NK cells (Fig. 4d) . To determine whether that reduction was due to generalized hyporesponsiveness, we activated NK cells with IL-12 and IL-18, which induced similar amounts of cytokines and chemokines (Fig. 4d) . These findings showed that Lck and Fyn recruited the PI(3)K subunit p85α and helped to form a p85α-p110δ complex, which regulated both NK cell-mediated cytotoxicity and cytokine production by NK cells.
NKG2D and CD137 require the scaffolding protein Lat Activation of PI(3)K produces phosphatidylinositol-(3,4,5)-trisphosphate, which is dephosphorylated to phosphatidylinositol-(4,5)-bisphosphate by the inositol phosphatases PTEN and SHIP. Phosphatidylinositol-(4,5)-bisphosphate serves as a substrate for PLC-γ2. Phosphorylation of PLC-γ requires molecular complex comprising the adaptor SLP-76, the tyrosine kinase Itk and the scaffolding protein Lat 14 . We found abundant phosphorylation of PLC-γ2 following NKG2D-or CD137-mediated activation (Fig. 4e) . Further, phosphorylation of protein kinase C-θ (PKC-θ) by diacylglycerol (a byproduct of the hydrolysis of phosphatidylinositol-(4,5)-bisphosphate by PLC-γ2) was also upregulated (Fig. 4f) . Preincubation of wild-type NK cells with an inhibitor of PLC-γ2 (U73122) or PKC (RO-31-8220) significantly reduced IFN-γ production ( Supplementary Fig. 3c ), which confirmed the requisite role of PLC-γ2 and PKC in cytokine production. To determine the role of Lat in this, we transfected NK cells with Lat-specific siRNA, which reduced the quantity of Lat protein (Supplementary Fig. 4a ). We transfected NK cells with Lat-specific siRNA and activated the cells via NKG2D or CD137 and found that Lat was more important for the production of cytokines and chemokines than for cytotoxicity ( Supplementary Fig. 4b,c) .
ADAP connects to the CBM signalosome
The Fyn-binding protein ADAP interacts with the carboxy (C)-terminal SH3-MAGUK ('membrane-associated guanylate kinase') region of Carma1 and thereby to the adaptors Bcl-10-MALT1 (to form the CBM signaling complex (signalsome)) 15 . Therefore, we investigated the role of the Fyn-ADAP complex in recruiting Carma1 downstream of NKG2D or CD137. We activated wild-type NK cells with platebound mAb to NKG2D or mAb to CD137, immunoprecipitated Lck from the cells and assessed Fyn and ADAP by immunoblot analysis (Supplementary Fig. 5a ). Although we found basal amounts of Fyn protein in association with Lck in unstimulated NK cells, its quantity was considerably increased following activation. We also noted a corresponding increase with ADAP ( Supplementary  Fig. 5a ), which indicated that an increase in the association of Fyn with CD137-Lck led to increased recruitment of ADAP. We further confirmed that by the impaired ability of Lck to form a signaling complex with ADAP, and, hence, with Carma1, in Fyn −/− NK cells (Supplementary Fig. 5b) .
Next we immunoprecipitated Fyn from NK cells to further confirm the recruitment of ADAP. Lysates of unstimulated wild-type NK cells contained a considerable amount of preformed Fyn-ADAP complexes (Supplementary Fig. 5c ). However, activation via NKG2D or CD137 augmented the association of Fyn with ADAP (Supplementary Fig. 5c ).
Carma1 was also present in the preformed Fyn-ADAP complexes in lysates of unstimulated NK cells (Supplementary Fig. 5c ). Both NKG2D-and CD137-mediated activation increased the amount of Carma1 protein that was associated with the Fyn-ADAP complexes (Supplementary Fig. 5c ). We further confirmed those observations in cells activated via the receptor NCR1 (Supplementary Fig. 5d ), which exclusively uses activation dependent on immunoreceptor tyrosine-based a c Fig. 5e ). The association of PKC-θ with Carma1 increased after activation mediated by either NKG2D or CD137; this did not require a physical association with PLC-γ2 (Supplementary Fig. 5e ). These results indicated that Lck and Fyn were able to facilitate the activation of Carma1 by recruiting ADAP into their complex.
ADAP regulates the production of inflammatory cytokines
To confirm the functional relevance of the biochemical findings reported above, we used mice deficient in ADAP (Fyb −/− ; called 'Adap −/− ' here) 16 . Expression of NKG2D and CD137 in NK cells was similar in wild-type and Adap −/− mice ( Supplementary  Fig. 5e ). Both wild-type and Adap −/− NK cells were fully able to mediate potent cytotoxicity against H60-or CD137L-expressing EL4 target cells (Fig. 5a) . However, activation mediated by either NKG2D or CD137 resulted in significantly less IFN-γ, GM-CSF, CCL3, CCL4 and CCL5 in Adap −/− NK cells than in their wild-type counterparts (Fig. 5b) . These results revealed an exclusive role for ADAP in regulating the production of inflammatory cytokines. Despite the similar amount of IFN-γ, GM-CSF and CCL5 in Adap −/− and wild-type NK cells, following activation mediated by IL-12 and IL-18, there was a significantly less production of CCL3 and CCL4 by Adap −/− NK cells than by wild-type cells (Fig. 5b) .
To determine if the impairment in cytokine production was intrinsic to NK cells and was not due to developmental defects, we generated mixed-bone marrow chimeras. We transferred equal numbers of bone marrow cells from wild-type (CD45.1 + B6.SJL) and Adap −/− (CD45.2 + C57BL/6) mice into lymphopenic mice deficient in both recombination-activating gene 2 and the common γ-chain ( Supplementary  Fig. 6a ). Six to eight weeks later, we analyzed the ability of freshly isolated splenic NK cells or NK cells that had been cultured with IL-2 to mediate cytotoxicity (assessed as CD107a expression) or cytokine production (assessed as IFN-γ + cells). Wild-type and Adap −/− NK cells had similar CD107a expression after activation mediated by NKG2D or CD137; however, there were moderately but significantly fewer CD107a + Adap −/− NK cells than CD107a + wild-type NK cells following activation via the receptor Ly49D, similar to published findings 17 ( Supplementary Fig. 6b ). Despite that difference, the frequency of cells with intracellular IFN-γ in the Adap −/− (CD45.2 + ) NK cell population was significantly less than that of the wild-type (CD45.1 + ) NK cell population. As freshly isolated NK cells had only minimal surface expression of CD137 (Supplementary Fig. 1a) , we did not observe a significant decrease in IFN-γ + cells after activation mediated by mAb to CD137. As expected, that reduction was much greater for NK cells cultured with IL-2 ( Supplementary Fig. 6c ). These results suggested that the impairment in cytokine production caused by the lack of ADAP was cell intrinsic.
To determine whether the defect was at the transcriptional level, we quantified Ifng mRNA by quantitative RT-PCR after activation mediated by NKG2D or CD137. Adap −/− NK cells had a significantly reduced number of Ifng mRNA copies relative to that in wild-type cells (Fig. 5c) , which confirmed a defect at the transcriptional level. We investigated the activation of AP-1 and NF-κB to determine the molecular mechanism by which ADAP regulates the transcription of genes encoding cytokines and chemokines. Lack of ADAP considerably reduced the translocation of c-Fos, c-Jun and p65 to the nucleus (Fig. 5d) . These findings confirmed a critical role for ADAP in linking Lck-Fyn to CBM signalosome-mediated activation of AP-1 and NF-κB.
The CBM signalosome and cytokine production To determine the role of the CBM complex, we first investigated the expression of NKG2D and CD137 in NK cells from wild-type mice, mice that specifically lack the N-terminal caspase-recruitment domain (CARD) of Carma1 (Carma1(∆CARD) mice) or Carma1 −/− mice. Lack of a CARD in Carma1 interrupts the recruitment of Bcl-10 to the CBM signalosome 18 . Our results showed that lack of a CARD or full-length Carma1 did not affect Fig. 6d ). Carma1(∆CARD) or Carma1 −/− NK cells consistently showed a moderately reduced ability to lyse H60-or CD137L-expressing EL4 target cells relative to that of wild-type NK cells (Fig. 6a) . However, Carma1(∆CARD) or Carma1 −/− NK cells showed significant impairment in their ability to produce inflammatory cytokines (Fig. 6b) . We further confirmed the crucial role of Carma1 and ADAP by culturing NK cells together with H60-or CD137L-expressing EL4 target cells. Analysis of culture supernatants of Carma1 −/− and Adap −/− NK cells revealed a significant reduction in the production of cytokines and chemokines compared with that of wild-type cells (Supplementary Fig. 7) . Stimulation of wild-type, Carma1(∆CARD) and Carma1 −/− NK cells with IL-12 and IL-18 showed that their responses were similar (Fig. 6b) . Quantification of Ifng mRNA showed that Carma1(∆CARD) and Carma1 −/− NK cells had significantly fewer copy numbers than did wild-type NK cells (Fig. 6c) . We also generated mixed-bone marrow chimeras of lymphopenic mice reconstituted with bone marrow cells from wild-type (CD45.1 + B6.SJL) and Carma1 −/− (CD45.2 + C57BL/6) mice. Analysis of those chimeras further confirmed that the reduction in IFN-γ production in the Carma1 −/− NK cells was cell intrinsic (Fig. 6d) .
We next analyzed the phosphorylation of PLC-γ2 and MAP3K7 downstream of CD137 (Supplementary Fig. 8a ) and NKG2D (data not shown). Lack of Carma1 or the CARD of Carma1 did not affect the phosphorylation of PLC-γ2; however, it resulted in a considerable reduction in the CD137-mediated phosphorylation of MAP3K7 relative to that in wild-type cells (Supplementary Fig. 8a) . Analysis of mitogen-activated protein kinases showed that Carma1(∆CARD) and Carma1 −/− NK cells had much less phosphorylation of Erk1-Erk2 and Jnk1-Jnk2 than did wild-type NK cells ( Supplementary  Fig. 8a ). Activation of p38 was not altered (Supplementary Fig. 8a) . Phosphorylation of the NF-κB inhibitor IκBα following CD137-mediated activation was reduced in Carma1(∆CARD) and Carma1 −/− NK cells relative to that in wild-type cells (Supplementary Fig. 8a) , which indicated inefficient activation of NF-κB. Furthermore, analysis of c-Fos, c-Jun, and NF-κB p65 in nuclear extracts following activation mediated by NKG2D or CD137 revealed that their activation and subsequent translocation to the nucleus were substantially reduced in Carma1 −/− NK cells compared with that in their wild-type counterparts (Supplementary Fig. 8b) . These results demonstrated a moderate and important role for the CBM signalosome in cytotoxicity and the production of inflammatory cytokines.
MAP3K7 links the CBM signalosome to cytokine production
To further confirm the role of MAP3K7, we used a conditional knockdown model 19 (Fig. 7a) . NK cells from poly (I:C)-treated Map3k7 fl/fl Mx1-Cre mice had slightly less CD137-mediated cytotoxicity against target cells than did NK cells from poly(I:C)-treated Map3k7 fl/fl or untreated Map3k7 fl/fl Mx1-Cre mice (Fig. 7b) . Knockdown of MAP3K7 significantly reduced the production of cytokines and chemokines (Fig. 7c) . Stimulation of NK cells from poly(I:C)-treated Map3k7 fl/fl or Map3k7 fl/fl Mx1-Cre mice with IL-12 and IL-18 resulted in comparable concentrations of cytokines and chemokines (Fig. 7c) . Collectively, these results demonstrated that MAP3K7 regulated CD137-mediated cytotoxicity and the production of inflammatory cytokines.
ADAP regulates cytokine production in human NK cells
To determine the role of ADAP in the effector function of human NK cells, we knocked down its expression through the use of ADAPspecific siRNA. We isolated NK cells from peripheral blood mononuclear cells (PBMCs) of healthy people (Fig. 8a) , transfected the cells with scrambled or ADAP-specific siRNA and assessed their cytotoxic potential and production of inflammatory cytokines. The use of ADAP-specific siRNA reduced the quantity of ADAP by >40% (Fig. 8b) . Knockdown of ADAP did not alter NK cell-mediated A r t i c l e s cytotoxicity against K562 human myelogenous leukemia target cells (Fig. 8c) . We also activated siRNA-transfected NK cells with mAb to NKG2D or mAb to CD137. We found that NK cells treated with scrambled or ADAP-specific siRNA had similar CD107a expression following activation mediated by mAb to NKG2D (Fig. 8c) , which confirmed that ADAP did not have a critical role in cytotoxicity. However, knockdown of ADAP significantly reduced the production of IFN-γ, GM-CSF, CCL3, CCL4 and CCL5 by primary human NK cells (Fig. 8d) . As human CD137 lacks the Lck-recruiting CRCP motif, activation with mAb to CD137 did not result in detectable cytotoxicity or production of cytokines (data not shown), as reported before 20 . These results confirmed a similar function for ADAP in mouse and human NK cells.
DISCUSSION
The activation of NK cells results in the lysis of target cells and production of inflammatory cytokines. However, the exclusive signaling requirement for each of those effector functions has not been determined. Our findings here have demonstrated that an ADAP-mediated signaling cascade that included a Carma1-based CBM signalosome had an exclusive and obligatory role in the production of inflammatory cytokines. The lysis of target cells and production of inflammatory cytokines via NKG2D and CD137 required Lck and Fyn. We found that CD137, but not NKG2D, constitutively associated with Lck, potentially through the use of the CRCP motif 6 , whereas both CD137 and NKG2D associated with Fyn. We further confirmed those findings by the increase in Fyn phosphorylation after activation mediated by NKG2D or CD137. Activation of Fyn is possibly mediated by Lck, which has been found to be juxtaposed to Fyn in the lipid raft, leading to the trans-phosphorylation of its catalytic domain 21 .
Fyn −/− NK cells were impaired in their ability to mediate cytotoxicity against EL4-H60 lo , EL4-CD137L lo or EL4-CD137L hi cells, similar to their effect on other target cells reported before 22 . However, the higher H60 expression in EL4-H60 hi cells provided a signaling threshold that overcame that impairment. Other Src kinases, such as Yes, Lyn, Hck, c-Fgr and Src, are expressed in NK cells 23, 24 , and whether an increased activation threshold makes Lck trans-phosphorylate any of these Src kinases remains to be determined. When we cultured Fyn −/− NK cells with EL4-H60 hi or EL4-CD137L hi target cells, they produced significantly reduced amounts of cytokines, which confirmed published observations 22 . However, activation of Fyn −/− NK cells with mAb to NKG2D or mAb to CD137 significantly augmented the production of inflammatory cytokines. Those findings are in line with published reports showing either augmented cytokine production 25 or unchanged cytokine production 26 in Fyn −/− cells of the immune system. Notably, we observed a difference between coculture and activation mediated by plate-bound antibodies in their effect on cytokine production only for Fyn −/− NK cells. None of the other mutant NK cells tested showed such a discrepancy.
NKG2D can directly recruit the PI(3)K subunit p85α via DAP10 (ref. 27). Unlike NKG2D-DAP10, CD137 does not contain a Tyr-X-Asn-Met (YXNM, where 'X' is any amino acid) motif. However, CD137-bound Lck, along with activated Fyn, can recruit p85α 28, 29 . Thus, the recruitment of p85α by Fyn 30 or by Lck-Fyn 28 can facilitate independent activation via CD137. That was supported by our study, as activation through CD137 resulted in increased interaction of Lck with Fyn and phosphorylation of Fyn. Immunoprecipitation of Fyn revealed its association with p85α. One possibility is that Fyn and, to a lesser extent, Lck interact with the two stretches of proline-rich regions in p85α via their SH3 domains 28 . p110δ is the main PI(3)K subunit required downstream of NKG2D in NK cells 31, 32 . The p110δ(D910A) NK cells had significantly less cytotoxic potential and production of inflammatory cytokines. PI(3)K activates PDK1, which has an important role in the phosphorylation of PKC-θ, which phosphorylates Carma1 and thereby links it to the CBM signalosome 33 . Lack of PLC-γ2, which depends on PI(3)K for its substrate phosphatidylinositol 4,5-bisphosphate, significantly reduces both the cytokine production and cytotoxic potential of NK cells 34 . Thus, the recruitment of p85α-p110δ to NKG2D-DAP10 or CD137-Lck (and Fyn) constitutes an important step required for NK cellmediated effector functions.
Fyn also associates with ADAP 35 . Activation mediated by NKG2D or CD137 increased the interaction between Fyn and ADAP. This is 37 . This could have been due to the fact that lack of ADAP does not alter the phosphorylation of Erk1-Erk2 and Jnk1-Jnk2 (refs. 15, 16) , which has a critical role in the mobilization of cytotoxic granules 38, 39 . However, the production of inflammatory cytokines was significantly reduced in Adap −/− NK cells, which indicated an exclusive requirement for ADAP in the transcription of their genes. The reverse is true for Vav1 −/− cells, in which cytotoxicity but not the production of inflammatory cytokines is substantially impaired 40 . The considerable reduction in the translocation of c-Fos, c-Jun and p65 to the nucleus confirmed ADAP as an obligatory linker of upstream signals to transcriptional regulation of cytokine-encoding genes. Although Fyn is directly upstream of ADAP, Fyn −/− NK cells were impaired in both cytotoxicity and cytokine production. This could have been due to the dual function of Fyn in both recruiting ADAP to link to the CBM signalosome and recruiting p85α for the activation of Erk1-Erk2 . The requirement for the CBM signalosome for the T cell antigen receptor and coreceptor CD28 in the T cell 41 , BCR in the B cell 18 and NKG2D in the NK cell 42 is well established. Our study has shown the presence of PKC-θ in a complex along with Lck, Fyn and ADAP, and Carma1 was recruited by ADAP after activation. Lack of the CARD of Carma1, full-length Carma1 or MAP3K7 moderately reduced the cytotoxicity of NK cells. The diminished phosphorylation of Erk1-Erk2 and Jnk1-Jnk2 in Carma1 −/− and Carma1(∆CARD) NK cells could have been the cause for that reduced cytotoxicity. Jnk1-Jnk2, which are regulated by MAP3K7 (ref. 43) , are critical for reorientation of the microtubule-organizing center, polarization and the exocytosis of cytotoxic granules containing perforin and granzyme 39 . Thus, our findings indicated that the CBM signalosome was at least partly responsible for regulating the cytotoxic function of NK cells. Our study has also confirmed the role of ADAP in human NK cells.
We found that unlike cytotoxicity, the production of inflammatory cytokines was significantly reduced in NK cells that lacked Carma1 or Map3k7. The CBM signalosome regulates the activation of NF-κB via the kinases IKKα and NEMO (IKKγ) and regulates the activation of Jnk2 via MAP3K7 (ref. 43) . AP-1 is made up of c-Jun and c-Fos, and the activation of c-Fos requires Erk1-Erk2 (ref. 44 ). MAP3K7, via Jnk2, regulates the activation of c-Jun 45 . We predict that the pathway mediated by the PI(3)K subunits p85α and p110δ and the GTPase Ras could be responsible for the activation of c-Fos and thus for the formation of AP-1 heterodimers and translocation of AP-1 to the nucleus.
In summary, we have demonstrated that downstream of NKG2D and CD137, Lck and Fyn initiated at least two distinct pathways. First, Lck and Fyn recruited p85α, which is critical for Ras-GTP-dependent activation of the kinases PAK1, then c-Raf, then MEK1-MEK2 and then Erk1-Erk2 that has a role mainly in cytotoxicity. Second, Fyn binds to ADAP, which leads to recruitment of the CBM complex that is mainly responsible for the production of inflammatory cytokines. Since ADAP also interacts with Fyn, Carma1 and MAP3K7 in T cells 15, 35 , we predict the existence of a conserved signaling pathway. Our results have identified potential therapeutic targets to exclusively minimize the production of inflammatory cytokines without compromising the cytotoxic potential of NK cells. lysis buffer containing Tris (pH 7.5, 20 mM), NaCl (150 mM), EDTA (1 mM), EGTA (1 mM), Triton-X100 (1%), sodium pyrophosphate (2.5 mM), β-glycerophosphate (1 mM), sodium orthovanadate (1 mM), leupeptin (1 ug/ml) and PMSF (1 mM). Lysates were centrifuged for removal of debris. For immunoprecipitation, 300-500 µg of each lysate was incubated for 1 h at 4 °C with 2 µg of the appropriate antibody (identified above). 20 µl of Protein G PLUS-Agarose (Santa Cruz Biotechnology) was added, followed by incubation overnight at 4 °C. After centrifugation, the supernatant was aspirated and beads were washed with the immunoprecipitation lysis buffer. SDS sample buffer (6×, reducing; BP-111R; Boston BioProducts), diluted to 1× concentration with the immunoprecipitation lysis buffer, was added to the bead pellet, followed by denaturation for 10 min at 95 °C. Samples were separated by 10% SDS-PAGE.
Immunoblot analysis. Whole-cell lysates (15-20 µg) or nuclear protein extracts (10 µg) isolated with NE-PER reagent (Pierce) were resolved by 10% SDS-PAGE, transferred to PVDF membranes and probed with the appropriate antibodies (identified above). Signals were detected with the SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific). Band intensities of phosphorylated proteins were normalized to those of the respective total protein. The change in phosphorylation after 5, 20, or 60 min of activation was calculated with those normalized values. For immunoprecipitation experiments, the induction of the protein after activation was calculated based on the basal amount of that protein in the unstimulated condition, after normalization to the protein immunoprecipitated, with ImageJ software.
Adoptive transfer. Bone marrow cells were isolated from CD45.1 + B6.SJL mice (4007; Taconic), CD45.2 + Adap −/− mice and CD45.2 + Carma1 −/− mice. B10;B6-Rag2 tm1Fwa II2rg tm1Wjl mice deficient in recombination-activating gene 2 and the common γ-chain (4111; Taconic) were used as recipients. Bone marrow cells from CD45.1 + wild-type and CD45.2 + mice were mixed (1 × 10 6 per genotype) and were injected retro-orbitally into the sublethally irradiated (800 cGy) recipient mice. After 4 weeks, spleen samples from the reconstituted mice were enriched for NK cells through the use of nylon wool as described 34 and were cultured overnight or for 7 d with 1,000 U/ml IL-2. Those NK cells were activated with plate-bound mAb to NKG2D, mAb to CD137 or mAb to Ly49D (identified above) and were analyzed by flow cytometry for surface expression of CD107a or for intracellular IFN-γ (antibodies identified above). Experimental data and statistical analysis. Total sample numbers were determined on the basis of previous studies (from our laboratories and other laboratories) with similar transgenic mouse models with comparable functional defects. Randomization method or 'blinding' of investigators to group allocation was not used. A paired, two-sample Student's t-test was used for statistical analysis, with equal or unequal variance, depending on the type of data. P values of 0.05 or less were considered significant. Normal distribution of sample variance was assumed on the basis of earlier studies from other laboratories with data sets similar to ours.
